(PharmaNewsWire.Com, May 30, 2017 ) According to Publisher, the Global Clinical Microbiology Market is accounted for $3.05 billion in 2015 and is expected to reach $6.72 billion by 2022 growing at a CAGR of 11.9% during the forecast period. Growing prevalence of infectious diseases, technological advancements, rising healthcare spending across the globe and public-private investments in the research field are some of the factors favouring the market growth. However, poor reimbursement policies and adverse regulatory scenario are hampering the market.
By geography, North America dominated the market with largest revenue. However, the Asia-Pacific market is anticipated to grow at the fastest CAGR due to the growing incidence of infectious diseases and increasing number of hospitals and clinical diagnostic laboratories in emerging countries such as India and China. Moreover, growing demand for advanced molecular diagnostic products provide ample of opportunities for the players in the global market.
Some of the key players in Clinical Microbiology market include Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, Inc., BioMérieux, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Alere Inc., Cepheid Inc, Siemens AG, Hologic, Inc. and Bruker Corporation.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: